Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQConsumer StaplesFood DistributionSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Cash flow from operations stays positive | Cash flow from operations turned positive at $1.1M in 2026-Q1. | Intact | cash flow turns negative again next year | Cash from operations: $-792,000 FY2026-Q2; GAAP. Published target: >0 USD. Target period is not explicitly aligned with this observation. Source published Aug 12, 2026-792,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 quarters including 2026-Q1, 2025-Q4, and 2025-Q1. Cash from operating activities improved from negative $1.37 million in 2025-Q1 to positive $1.13 million in 2026-Q1. The annual 2025 cash flow was negative $2.8 million. The trajectory shows delivering improvement in cash flow management. Delivery assessment Oct 24, 2026 |
New CFO supports financial and operational goals | A new CFO may help fix financial problems. | Under Pressure | financial results worsen after CFO transition | Equity <$2.5M vs >=$2.5M target Nasdaq notified company of non-compliance with $2.5M minimum equity requirement in April 2026. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextNewly stated in 2026-Q2 with the announcement of Yasir Haider promoted to CFO replacing James Clavijo. No financial metrics directly tied to this priority yet. Trajectory is newly initiated. Delivery assessment Oct 24, 2026 |
Operating income improves to positive levels | A primary condition in Mannatech Inc's published investment case. The stated target is >0 USD. | Broken | operating income remains negative over next 4 quarters | Operating income: $998,000 FY2026-Q2; GAAP. Published target: >0 USD. Target period is not explicitly aligned with this observation. Source published Aug 12, 2026998,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 08aaad56-2810-46da-aba3-7163b9263a79. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 4 quarters including 2026-Q2, 2026-Q1, 2025-Q4, and 2025-Q3. Income from operations improved from a loss of $1.4 million in 2025-Q2 to a positive $1.0 million in 2026-Q2. Net income turned positive to $1.0 million in 2026-Q2 from a loss of $4.3 million in 2025-Q2. The trajectory shows delivering improvement in profitability. Delivery assessment Oct 24, 2026 |
Quarterly revenue holds near $25M | Management focuses on keeping revenue near $25M quarterly. | Intact | revenue falls below $24.9M consistently next year | Revenue: $26.65M FY2026-Q2; GAAP. Published target: >=24.9M USD. Target period is not explicitly aligned with this observation. Source published Aug 12, 202626,650,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 08aaad56-2810-46da-aba3-7163b9263a79. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 quarters including 2026-Q2, 2026-Q1, and 2025-Q4. Net sales increased by $1.0 million from $25.7 million in 2025-Q2 to $26.7 million in 2026-Q2, a 5.1% constant dollar increase. However, sales declined in 2026-Q1 and 2025-Q4 compared to prior year quarters. The trajectory is mixed with recent growth but prior declines. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk turnaround thesis, not a proven durable compounder. The thesis is on watch: results have improved and the signal recently shifted to mildly favorable, but performance remains below its industry cohort.
The evidence describes MTEX as cheap versus peers, while also showing a peer premium and low confidence in the valuation model. The expectations gap is negative, but the snapshot does not explain its scale in plain terms; overall, priced-in fragility is rated low.
Near term, earnings risk is elevated, and the company has missed in recent quarters. Over the multi-year view, operating income and net income improved to positive levels in 2026-Q2, while sales rose 5.1% in constant dollars; cash flow also improved in 2026-Q1, though annual 2025 operating cash flow was negative. Recent accountant-change filings and a litigation filing add uncertainty, while revenue trends and management execution remain mixed.
The multi-year thesis depends on sustained profitability, revenue growth, and stronger cash generation. Near term, weakening jobs data could increase recession concerns, while continued strong results from sector bellwethers SYY, USFD, and PFGC could support sector momentum; misses or lower guidance from those companies could remove that support.
Over the next 1 to 3 years, MTEX’s thesis rests on whether recent financial improvement becomes consistent, despite elevated earnings risk and legal uncertainty. The evidence is mixed, and confidence in the valuation model is low. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.